EvokAI Creative Labs Inc.

Equities

OKAI

CA30053J1012

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. 20:15:59 30/04/2024 BST 5-day change 1st Jan Change
0.13 CAD -.--% Intraday chart for EvokAI Creative Labs Inc. -.--% +73.33%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
EvokAI Creative Labs Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
EvokAI Creative Labs Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
EvokAI Creative Labs Inc. Receives Ce Mark Approval for Its Mdm Flex Sensor to Transform the Management of Parkinson's Disease CI
EvokAI Creative Labs Inc. completed the acquisition of Rehaboo Oy. CI
EvokAI Creative Labs Closes Acquisition of Extended Reality AI-Powered Company Neurocarrier Oy MT
EvokAI Creative Labs Inc. completed the acquisition of NeuroCarrier Oy. CI
EvokAI Creative Labs Inc. entered into a definitive agreement to acquire NeuroCarrier Oy. CI
EvokAI Creative Labs Inc. completed the acquisition of Head Instruments Oy. CI
EvokAI Creative Labs Inc. entered into a Share Purchase Agreement to acquire Rehaboo Oy for $4 million. CI
EvokAI Creative Labs Inc. Auditor Raises 'Going Concern' Doubt CI
EvokAI Creative Labs Inc. entered into a definitive agreement to acquire Head Instruments Oy for €4.4 million. CI
EvokAI Creative Labs Inc. acquired Sebastiani Ventures Corp. (TSXV:SBS.H) in a reverse merger transaction CI
Sebastiani Ventures Corp. Announces Board Appointments CI
Sebastiani Ventures Corp. Appoints Alejandro Antalich as Chief Executive Officer CI
EvokAI Creative Labs Inc. announced that it has received CAD 5 million in funding from Sebastiani Ventures Corp. CI
Sebastiani Ventures Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
EvokAI Creative Labs Inc. announced that it expects to receive CAD 5 million in funding from Sebastiani Ventures Corp. CI
EvokAI Creative Labs Inc. entered into a binding letter of intent to acquire Sebastiani Ventures Corp. (TSXV:SBS.H) in a reverse merger transaction. CI
Sebastiani Ventures Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Sebastiani Ventures Corp. announced that it has received CAD 0.25 million in funding CI
EvokAI Creative Labs Inc. acquired 96% stake in Advancience Ltd from Baden Resources Limited for $2.05 million. CI
Sebastiani Ventures Corp. announced that it expects to receive CAD 0.25 million in funding CI
Sebastiani Ventures Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Sebastiani Ventures Corp. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Sebastiani Ventures Corp. Auditor Raises 'Going Concern' Doubt CI
Chart EvokAI Creative Labs Inc.
More charts
EvokAI Creative Labs Inc. is a MedTech artificial-intelligence-powered company. It is engaged in the development of transformational technologies for the modern health care sector. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. It offers its AI algorithms across the whole health care system, from hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations to medical professionals, patients, and healthy individuals, aiming at preventing and early detecting any kind of disease and protecting the aging genome. Its divisions include EvokAI Simulators, EvokAI Sensors, EvokAI Neurotrainer and EvokAI Medical. EvokAI Simulators combines cognitive neuroscience, virtual reality and artificial intelligence technologies to assess cognitive performance and spatial perception.
More about the company
  1. Stock Market
  2. Equities
  3. OKAI Stock
  4. News EvokAI Creative Labs Inc.
  5. EvokAI Creative Labs Closes Acquisition of Extended Reality AI-Powered Company Neurocarrier Oy